Marimed (MRMD) EBT Margin (2011 - 2026)

Marimed (MRMD) has 16 years of EBT Margin data on file, last reported at 2.83% in Q1 2026.

• EBT Margin for Q1 2026 came in at 2.83%, up 416.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 5.7% (down 122.0% YoY), and the FY2025 annual result was 6.8%, down 409.0% from the prior year.
• EBT Margin advanced to 2.83% in Q1 2026 per MRMD's latest filing, from 17.59% in the prior quarter.
• Over five years, EBT Margin peaked at 25.26% in Q1 2022 and troughed at 24.76% in Q4 2023.
• A 5-year average of 0.22% and a median of 0.45% in 2025 frame the typical range for EBT Margin.
• The sharpest annual moves came in 2023 and 2024: EBT Margin plunged 3245 bps in 2023, then surged 1624 bps in 2024.
• A 5-year view of EBT Margin shows it stood at 7.69% in 2022, then tumbled by 422 bps to 24.76% in 2023, then surged by 66 bps to 8.51% in 2024, then slumped by 107 bps to 17.59% in 2025, then surged by 84 bps to 2.83% in 2026.
• Business Quant data shows MRMD's EBT Margin at 2.83% in Q1 2026, 17.59% in Q4 2025, and 0.45% in Q3 2025.